Hirohiko Hasegawa

Discovery and optimization of a novel series of liver X receptor-α agonists

Leping Li, Jiwen Liu, Liusheng Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 61 citations · Full text

Molecular Pharmacology, Novel Series, Biochemistry +8

Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure–activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives

Hirohiko Hasegawa, Masami Muraoka, Kazuki Matsui et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 57 citations

Pharmacological Characterization of a Novel Sulfonylureid-Pyrazole Derivative, SM-19712, a Potent Nonpeptidic Inhibitor of Endothelin Converting Enzyme

Kayo Umekawa, Hirohiko Hasegawa, Y Tsutsumi et al. · The Japanese Journal of Pharmacology · 2000 · 42 citations · Full text

Pharmacological Characterization, Big Endothelin-1, Pharmacotherapy +16

Synthesis of sodium-polystyrenesulfonate-grafted nanoparticles by core-cross-linking of block copolymer micelles

Kozo Matsumoto, Hirohiko Hasegawa, Hideki Matsuoka · Tetrahedron · 2004 · 35 citations

Chemical Engineering, Block Co-polymers, Engineering +8

Design, synthesis and biological activity of novel non-peptidyl endothelin converting enzyme inhibitors, 1-phenyl-tetrazole-formazan analogues

Kazuto Yamazaki, Hirohiko Hasegawa, Kayo Umekawa et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 21 citations · Full text

Biological Activity, Medicinal Chemistry, Biochemistry +11